ニュース · QuantAbundancia

Motley Fool8h agobullish

Why ImmunityBio Stock is Soaring Higher Today

ImmunityBio's stock is moving higher after the FDA announced it would review a possible label expansion for the company's core Anktiva drug.

Benzinga1d agobullish

ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership

ImmunityBio Inc. on Monday said it entered an exclusive U.S. Development and Supply Agreement with Japan BCG Laboratory to develop, import, and commercialize the Tokyo strain of BCG for bladder cancer treatment in the U.S. ImmunityBio Secures Exclusive Rights To...

Insider Monkey17d agobullish

Is ImmunityBio, Inc. (IBRX) A Good Stock To Buy Now?

Is IBRX a good stock to buy? We came across a bullish thesis on ImmunityBio, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on IBRX. ImmunityBio, Inc.’s share was trading at $8.10 as of April 21st. ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and […]

IBRX

Zacks23d agobullish

What Makes ImmunityBio (IBRX) a New Buy Stock

ImmunityBio (IBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

IBRX